Novo Nordisk has submitted an application to the FDA seeking approval of Mim8 for the treatment of people with hemophilia A.
Initial $100 million term loan to propel market share growth in the U.S.SAN DIEGO, Sept (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback